Common Class A Class of Stock [Axis] Common Class B Stock Warrants [Member] Class Of Warrant Or Right [Axis] Kard Scientific [Member] Related Party [Axis] Clinical Studies [Member] Patents [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents Two [Member] Patents Three [Member] Year 2018-2025 [Member] Year 2026 [Member] Year 2027 [Member] Year 2028 [Member] Year 2029 and 2032 [Member] Year 2033 [Member] Stock Options [Member] Award Type [Axis] Minimum and Intangible Assets - Patent (Member) Range [Axis] Maxiimum and Intangible Assets - Patent (Member) Innovative Medical Research Inc [Member] Minimum [Member] Maximum [Member] On June 27, 2016 [Member] Award Date [Axis] On September 1, 2016 [Member] On February 16, 2016 [Member] On April 6, 2016 [Member] 30 Million Common Stock Purchase Agreement [Member] Agreement [Axis] Aspire Capital Fund Llc [Member] Legal Entity [Axis] Restricted Stock [Member] Year 2017 [Member] Year 2034 [Member] Mr. Ehrlich [Member] Related Party Transaction [Axis] Ehrlich Promissory Note C [Member] Ehrlich Promissory Notes A and B [Member] 2010 Equity Incentive Plan [Member] 2016 Equity Incentive Plan [Member] On June 30, 2016 [Member] On December 31, 2010 [Member] December 31, 2016 [Member] Consultant [Member] September 1, 2016 [Member] On September 15, 2016 [Member] September 15, 2016 [Member] July 10, 2015 [Member] Issuance of Common Stock to Consultants For Services [Member] August 1, 2016 [Member] July 18, 2016 [Member] July 10, 2016 [Member] Issuances of Common Stock and Stock Options [Member] 2009 Stock Option Plan [Member] On April 5, 2009 [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Trading Symbol Current Fiscal Year End Date Entity Filer Category Document Type Document Period End Date Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Entity Common Stock, Shares Outstanding Statement [Table] Statement [Line Items] ASSETS Current Assets: Cash Prepaid expenses Subscription receivable Total Current Assets Other Assets: Patent costs - net Property, plant and equipment -net Deferred offering costs Security deposits Total Other Assets Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable - (including related party payables of approx. $1,504,000 and $1,502,000, respectively) Accrued expenses - (including related party accruals of approx. $139,000 and $72,000, respectively) Accrued salaries and payroll taxes -(including related party accrued salaries of approx. $2,777,000 and $2,777,000, respectively) Note payable - related party Total Current Liabilities Total Liabilities Commitments and contingencies (Note 8) Stockholders' Equity Preferred stock, $0.001 par value, 500,000 designated shares, no shares issued and outstanding Common Stock, Value Additional paid-in capital Accumulated deficit Total Stockholders' Equity Total Liabilities and Stockholders' Equity Accounts payable, related party payables (in dollars) Accrued expenses, related party accruals (in dollars) Accrued salaries, due to related parties (in dollars) Preferred stock, par value (in dollars per share) Preferred stock, shares designated (in shares) Preferred stock, shares issued (in shares) Preferred stock, shares outstanding (in shares) Common Stock, par value (in dollars per share) Common Stock, shares authorized (in shares) Common Stock, shares issued (in shares) Common Stock, shares outstanding (in shares) Condensed Statements Of Operations Revenues Operating expenses: Research and development expenses General and administrative expenses Officers' payroll and payroll tax expenses Professional fees Total operating expenses Loss from operations Other income (expenses) Interest income Interest expense Total other income (expenses) Loss before provision for income taxes Provision for income taxes Net loss Basic and diluted loss per share attributable to common stockholders Weighted average number of common shares outstanding Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Common stock and stock options issued as payment for services Amortization of patent costs Depreciation of equipment Changes in operating assets and liabilities: Prepaid expenses and other current assets Accounts payable Accrued expenses Accrued officers' salaries and payroll taxes Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Additions to property, plant and equipment Patent costs Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Sale of common stock Exercise of stock options and warrants Net cash provided by financing activities NET DECREASE IN CASH CASH, BEGINNING OF PERIOD CASH, END OF PERIOD SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Cash paid for interest Notes to Financial Statements Note 1 - Basis of Presentation and Nature of Operations Note 2 - Liquidity Note 3 - Significant Accounting Policies and Recent Accounting Pronouncements Note 4 - Patents, net Note 5 - Accounts Payable Note 6 - Accrued Expenses Note 7 - Accrued Salaries and Payroll Taxes - Related Parties And Other Note 8 - Commitments and Contingencies Note 9 - Related Party Transactions Note 10 - Note Payable - Related Party Note 11 - Equity Incentive Plans, Stock-Based Compensation and Warrants Note 12 - Equity Transactions Note 13 - Subsequent Events Significant Accounting Policies And Recent Accounting Pronouncements Policies Reclassifications Use of Estimates Basic Earnings (Loss) per Share Accounting for Stock Based Compensation Recent Accounting Pronouncements Significant Accounting Policies And Recent Accounting Pronouncements Tables Schedule of components of stock based compensation related to stock options recognized in the company's statement of operations Patents Net Tables Schedule of patents Accounts Payable Tables Schedule of Accounts payable Accrued Expenses Tables Schedule of accrued expenses Accrued Salaries And Payroll Taxes - Related Parties And Other Tables Schedule of accrued salaries and payroll taxes Commitments And Contingencies Tables Future minimum lease payments required under the non-cancelable operating lease Class of Warrant or Right [Axis] Valuation assumptions for stock options/warrants and SARs Schedule of stock option activity Equity Transactions Tables Schedule of Restricted Stock Award Activity Schedule of vesting outstanding restricted stock Liquidity Details Narrative Cash and cash equivalents Working capital (deficit) Purchase of common stock Purchase Agreement Term Common stock purchase available balance Future expenses Clinical trials expenses Significant Accounting Policies And Recent Accounting Pronouncements Details General and administrative expenses Professional fees Research and development expenses Professional fees Employees' bonus Officers' bonus Total share-based compensation expense Significant Accounting Policies And Recent Accounting Pronouncements Detail Narrative Diluted earnings (loss) per share Useful life Purchased Patent Rights Accumulated amortization Estimated remaining useful lives of the assets Amortization expense Amortization period Estimated annual amortization expense Accounts Payable Details Accounts payable Accounts payable (Note 9) – related parties Total Accounts Payable Details Narrative Start-up fees Income from reversal of this accounts payable Accrued Expenses Details Accrued research and development consulting fees Accrued rent (Note 9) – related parties Accrued interest (Note 10) related parties Total Accrued Salaries And Payroll Taxes - Related Parties And Other Details Accrued salaries - related parties Accrued payroll taxes - related parties Withholding tax Total Commitments And Contingencies Details Year ending June 30, 2017 2018 2019 Total minimum payments Commitments And Contingencies Details Narrative Operating leases, rental expense Lease term Lease expiry date Monthly payament on lease Monthly payment on lease by officers Area used by officers Rental income Rent expense Rent payables Accrued research and development expenses Interest accrued Principal balances of the demand note Additional loan balance Bears interest rate Common stock per share Equity Incentive shares Options exercisable Closing bid price per share Number of Outstanding, Beginning Balance Granted Exercised Forfeited/expired Number of Outstanding, Ending Balance Number of Outstanding, Exercisable Weighted Average Exercise Price, Beginning Balance Granted Exercised Forfeited/expired Weighted Average Exercise Price, Ending Balance Weighted Average Exercise Price, Exercisable Weighted average remaining contractual life (Years), Outstanding, Beginning Balance Weighted average remaining contractual life (Years), Granted Weighted average remaining contractual life (Years), Outstanding, Ending Balance Weighted average remaining contractual life (Years), Exercisable Aggregate intrinsic value, Beginning Balance Aggregate intrinsic value, Ending Balance Aggregate intrinsic value, Exercisable Expected term (in years) Expected stock price volatility Risk-free interest rate Expected dividend yield Extended Granted Expired Extended Expired Weighted average remaining contractual life (Years), Extended Weighted average remaining contractual life (Years), Outstanding, Ending Balance Exercise price Exercisable period Common stock shares reserved and issuance Restricted stock Shares and options shall vest description Common stock closing preice Stock based compensation Stock option expenses Stock awards Stock based compensation description Stock options to purchase par value $0.0001, shares Stock options to purchase par value $0.0001, value Stock option exercise price Stock issued, Shares Stock issued, per share Stock issued, Value Annual salary Option issued Option issued value Incentive Stock Options Total shares granted Total shares granted Scheduled vesting - restricted stock Agreement [Domain] Number of common stock shares sold Value of common stock shares sold Number of common stock shares purchase Restricted stock and options issued Unrecognized compensation Expected compensation Compensation weighted average recognition period Term of the Purchase Agreement Commitment fee Shelf registration statement on Form S-3 Subscription receivable Exercise of common Stock options Option to purchase of copmmon stock Common Stock Purchase Agreement Sale of common stock Ac crude Expense To Related Party [Text Block] Accrued Consulting Fee, Current Accrued research and development expenses. Accrued Salaries Due To Related Parties, Current Accrued salaries payroll taxes. Additions to property plant and equipment. Agreement [Axis] Clinical Studies. Consultant. Issuance Of Stock and Stock Options For Services Compensation, Rendered and Charitable Contributions Kard Scientific [Member] Notes Payable To Related Party [Text Block] Patents Four [Member] Patents Three [Member] Patents Two [Member] Schedule Of Accrued Salaries and Payroll Taxes [Table Text Block] Withholding Tax Related Parties Year 2026. Year 2027. Year 2028. Year 2029. Finite Lived Intangible Assets Amortization Expense Rolling For Future Year Extended. Extended. Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual life extended. Share Based Compensation Arrangement By Share Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term Agreement [Domain] Aspire Capital Fund Llc [Member] Common stock purchase agreement two. Common Stock Purchase Agreement [Member] Common stock purchase agreement. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Monthly payament on lease. Monthly payment on lease by officers. Area used by officers. Common stock purchase agreement. Sale of common stock. Assets, Current Other Assets Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Increase (Decrease) in Prepaid Expense Net Cash Provided by (Used in) Operating Activities, Continuing Operations AdditionsToPropertyPlantAndEquipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash, Period Increase (Decrease) General and Administrative Expense [Abstract] ProfessionalFees1 Research and Development Expense [Abstract] Professional and Contract Services Expense Accounts Payable, Trade, Current Accrued Liabilities AccruedSalariesPayrollTaxes Capital Leases, Future Minimum Payments Due Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExtendedInPeriodWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3 Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Subscription and Circulation Revenue SaleOfCommonStock PatentsFourMember AgreementDomain CommonStockPurchaseAgreementTwoMember CommonStockPurchaseAgreementMember CommonStockPurchaseAgreementOneMember